COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 71 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,700,835 | +5.1% | 76,100 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $1,618,197 | -2.1% | 75,300 | +9.3% | 0.00% | 0.0% |
| Q1 2023 | $1,652,911 | -8.9% | 68,900 | -11.9% | 0.00% | 0.0% |
| Q4 2022 | $1,814,240 | +46.3% | 78,200 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $1,240,000 | -9.6% | 77,400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,372,000 | -8.4% | 77,400 | +5.2% | 0.00% | 0.0% |
| Q1 2022 | $1,498,000 | +14.4% | 73,600 | +5.0% | 0.00% | 0.0% |
| Q4 2021 | $1,309,000 | -5.4% | 70,100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,384,000 | -15.0% | 70,100 | +1.7% | 0.00% | 0.0% |
| Q2 2021 | $1,629,000 | -3.3% | 68,900 | -3.1% | 0.00% | 0.0% |
| Q1 2021 | $1,685,000 | +20.2% | 71,100 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $1,402,000 | -3.8% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,457,000 | +23.7% | 70,000 | +4.0% | 0.00% | 0.0% |
| Q2 2020 | $1,178,000 | +38.8% | 67,300 | +29.4% | 0.00% | 0.0% |
| Q1 2020 | $849,000 | -19.4% | 52,000 | +1.6% | 0.00% | 0.0% |
| Q4 2019 | $1,054,000 | +85.2% | 51,200 | +3.2% | 0.00% | 0.0% |
| Q3 2019 | $569,000 | -12.7% | 49,600 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $652,000 | +4.8% | 49,600 | +20.7% | 0.00% | 0.0% |
| Q1 2019 | $622,000 | -11.9% | 41,100 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $706,000 | +26.1% | 41,100 | +8.2% | 0.00% | 0.0% |
| Q3 2018 | $560,000 | -38.2% | 38,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $906,000 | -6.7% | 38,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $971,000 | +73.7% | 38,000 | +25.4% | 0.00% | 0.0% |
| Q4 2017 | $559,000 | +75.8% | 30,300 | 0.0% | 0.00% | – |
| Q3 2017 | $318,000 | -16.1% | 30,300 | 0.0% | 0.00% | – |
| Q2 2017 | $379,000 | +24.3% | 30,300 | 0.0% | 0.00% | – |
| Q1 2017 | $305,000 | -35.4% | 30,300 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $472,000 | +36.8% | 30,300 | +69.3% | 0.00% | 0.0% |
| Q3 2016 | $345,000 | +62.7% | 17,900 | 0.0% | 0.00% | – |
| Q2 2016 | $212,000 | – | 17,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |